Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Open-Label Extension Study (to Study 99784) of Gaboxadol in Primary Insomnia

NCT00209950 is registered in ClinicalTrials.gov with H. Lundbeck A/S as lead sponsor.

NCT NCT00209950
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00209950 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Open-Label Extension Study (to Study 99784) of Gaboxadol in Primary Insomnia
Lead sponsor
H. Lundbeck A/S
Phase
Phase 3
Overall status
Completed
Start date
July 31, 2004
Completion date
September 30, 2005
Enrollment
200
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

primary insomnia